MARC Record from marc_columbia

LEADER: 03768cam a2200445Ii 4500
001 11730355
005 20160321130014.0
008 150828t20152015dcua b 100 0 eng d
019 $a919343324
020 $a9780309376181
020 $a0309376181
035 $a(OCoLC)ocn919483549
035 $a(OCoLC)919483549$z(OCoLC)919343324
035 $a(NNC)11730355
040 $aBTCTA$beng$erda$cBTCTA$dYDXCP$dNRZ$dOCLCO$dNRZ$dOCLCO$dKSU$dOCLCO$dOCLCF$dOCLCO
050 4 $aR856.A2$bN66 2015
111 2 $aNon-Invasive Neuromodulation of the Central Nervous System (Workshop)$d(2015 :$cWashington, D.C.),$jauthor.
245 00 $aNon-invasive neuromodulation of the central nervous system : opportunities and challenges : workshop summary / Lisa Bain, Sheena Posey Norris, and Clare Stroud, Rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, and Medicine.
264 1 $aWashington, D.C. :$bNational Academies Press,$c[2015]
264 4 $c© 2015
300 $axii, 108 pages :$bcolor illustration ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $aSummary of Non-Invasive Neruomodulation of the Central Nervous System: A Workshop which took place in Washington D.C. on March 2-3, 2015.
520 $a"Based on advances in biotechnology and neuroscience, non-invasive neuromodulation devices are poised to gain clinical importance in the coming years and to be of increasing interest to patients, clinicians,health systems, payers, and industry. Evidence suggests that both therapeutic and non-therapeutic applications of non-invasive neuromodulation will continue to expand in coming years, particularly for indications where treatments are currently insufficient, such as drug-resistant depression. Given the growing interest in non-invasive neuromodulation technologies, the Institute of Medicine's Forum on Neuroscience and Nervous System Disorders convened a workshop, inviting a range of stakeholders - including developers of devices and new technologies, researchers, clinicians, ethicists, regulators, and payers - to explore the opportunities, challenges, and ethical questions surrounding the development, regulation, and reimbursement of these devices for the treatment of nervous system disorders as well as for non-therapeutic uses, including cognitive and functional enhancement. This report highlights the presentation and discussion of the workshop"--Publisher's description.
504 $aIncludes bibliographical references (pages 75-83).
505 0 $aOverview of gaps, challenges, and potential opportunities -- The science and technology of non-invasive neuromodulation -- Therapeutic uses of non-invasive neuromodulation -- Using non-invasive neuromodulation for diagnosis and research -- Enhancement of brain function and performance -- Ethical, legal, and social Issues -- Regulatory issues -- Reimbursement issues -- The business environment -- Appendixes.
650 0 $aNeurology$vCongresses.
650 0 $aBiotechnology$vCongresses.
650 0 $aMedical instruments and apparatus$vCongresses.
650 7 $aBiotechnology.$2fast$0(OCoLC)fst00832729
650 7 $aMedical instruments and apparatus.$2fast$0(OCoLC)fst01014194
650 7 $aNeurology.$2fast$0(OCoLC)fst01036390
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
700 1 $aBain, Lisa J.,$erapporteur.
700 1 $aNorris, Sheena M. Posey,$erapporteur.
700 1 $aStroud, Clare,$erapporteur.
710 2 $aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
852 00 $boff,sci$hR856.A2$iN66 2015g